BTAI icon

BioXcel Therapeutics

85 hedge funds and large institutions have $140M invested in BioXcel Therapeutics in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 32 increasing their positions, 28 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

16% less capital invested

Capital invested by funds: $167M → $140M (-$27.2M)

53% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 15

Holders
85
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.56M
Puts
$933K
Net Calls
Net Calls Change

Top Sellers

1 -$5.17M
2 -$2.49M
3 -$1.17M
4
Two Sigma Investments
Two Sigma Investments
New York
-$991K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$976K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$49.6M
2
$17.3M
3
$16.3M
4
$12.2M
5
$5.37M
6
$4.37M
7
$4.2M
8
$3.01M
9
$2.57M
10
$2.46M
11
$1.7M
12
$1.66M
13
$1.46M
14
$1.28M
15
$1.11M
16
$1.05M
17
$878K
18
$819K
19
$771K
20
$765K
21
$675K
22
$668K
23
$638K
24
$616K
25
$591K